Leuprolide Acetate Depot 22.5 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Leuprolide Acetate Depot 22.5 mg, covering 2017-01-18 to 2017-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer [Phase 3]